Moreover, our analysis of high-grade serous ovarian tumors indicated that patients with cisplatin resistance exhibited low levels of Fn14 protein (IHC analysis) (p < 0.05, Fig. 1a and b). This evidence concerns the gene TNFRSF12A and ovarian serous tumor.